Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

EACR 2022

Sevilla , Spain

Meet Scandion Oncology at the EACR 2022 Congress

BACR

Nottingham , United Kingdom

Meet Scandion Oncology at the BACR 60th Anniversary Meeting

Interim report Q2 2022

Scandion Oncology (Scandion) will publish its Q2 2022 interim report on Thursday, August 25, 2022 before 09:00 CET. Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update. At the end of the presentation there will be a Q&A session. Access to the event can be obtained as follows: LIVE access on Thursday August 25, 2022 at 10:00 CET https://financialhearings.com/event/43548  

LSX Nordic Congress

Copenhagen , Denmark

Meet Scandion Oncology at LSX Nordic 2022

DAF Nordsjælland

Scandion Oncology, Fruebjergvej 3, 2100 Copenhagen , Denmark

We will give a presentation and update on Scandion followed by a Q&A session Read more Download presentation

Investor AW – Malmö

We will give a presentation and update on Scandion followed by a Q&A session. Watch the presentation here  

Bio-Europe 2022

We will give a presentation and update on Scandion followed by a Q&A session.

Interim report Q3 2022

Scandion Oncology will publish its Q3 2022 interim report on Wednesday November 16, 2022, before 09:00 CET. Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update. At the end of the presentation there will be a Q&A session. Access to the event can be obtained as follows: LIVE access on Wednesday November 16, 2022, at 10:00 CET Webcast: https://financialhearings.com/event/45864 Dial-in: DK: +4578150110 SE: +46850558354 UK: +443333009266 US: +1 6319131422 PIN US: 42830998# REPLAY access Webcast replay will be available at http://www.scandiononcology.com in the Investors section and at http://www.financialhearings.com For further information please contact: Johnny Stilou, Acting CEO & CFO Phone: +45 2960 3532 E-mail: jos@scandiononcology.com